Significance of experimental infarct size as an indicator of therapeutic efficacy in humans.

Sakellaridis, Nikolaos

Significance of experimental infarct size as an indicator of therapeutic efficacy in humans. [electronic resource] - Stroke Sep 2007 - e89-90 p. digital

Publication Type: Comment; Letter

1524-4628

10.1161/STROKEAHA.107.481853 doi


Animals
Cerebral Infarction--diagnosis
Humans
Nitric Oxide Synthase Type II--antagonists & inhibitors
Prognosis
Treatment Outcome
Tumor Necrosis Factor-alpha--metabolism